Beruflich Dokumente
Kultur Dokumente
ATRIAL FIBRILLATION
Department of Cardiology Faculty of Medicine
Syiah Kuala University, Aceh, Indonesia
March, 2015
Presented: Supervisor:
Maryamah dr. Hj. Sri Murdiati, Sp. JP (K) - FIHA
Background
European Society of Cardiology. Guidelines for the management of atrial fibrillation. European Heart Journal. 2010. 31.
p.2369–2429.
6%
PSVT
Atrial fibrillation
accounts for 1/3 of 6%
PVCs 18%
all patient Unspecified
4%
discharges Atrial
with arrhythmia as Flutter
principal diagnosis.
9% 34%
SSS Atrial
Fibrillation
8%
Conduction
Disease
10% VT
3% SCD
2%VF
ATRIAL FIBRILLATION
Hemodynamically
stable
Yes No
Unstable…
•Hypotension
Control ventricular rate: •Confusion
Cardioversion
Diltiazem •Angina
•Beta Blockers •….
•Calcium Channel
blockers
•Digoxin Long standing HTN
•Amiodarone Ischemic heart dz
Spontaneous conversion to sinusCHF
rhythm
Hyperthyroidism
Yes PE No
Lung ca
Alcohol
Assess cause of
Contraindication to cardioversion?
Hypothermia
atrial fibrillation Electrolytes imbalance
Etc. .
Cont’
Cont’
Yes No
Cardiversion
Start Heparin IV
Consider long-term
Warfarin Aspirin
<48hs >48hs
anticoagulation
Conc: Aortosclerosis
• Serial ECG
• laboratory (profile of lipid, ureum, creatinin,
electrolit)
• Echocardiografi
Treatments
March 20th 2015
• IVFD RL 10 gtt/menit
• Inj. Digoxin 1 amp (ekstra)
• Inj. Ranitidin 1 amp/12 h
• Simarc (warfarin) 1x2mg (night)
• Diovan 1x80 mg
March21st 2015
• Heart palpitation is reduce
• Changed Inj. Digoxin to Digoxin 1x1 tab
• Inj Lasix 1 amp/12 h
March 23rd 2015
• Digoxin stop
• Simarc stop
• V-Block ½ tab (morning)
March 26th 2015: Home recipes
• diovan 1x80 mg
• lasix 1x1 tablet
Prognosis